News

February 4, 2015

AAB and NILA Release Comments on FDA's Draft Guidances on LDTs

Click below to download and read AAB and NILAs comments and the FDA's draft guidances:

NILA/AAB Press Release on LDTs 

Click to view AAB/NILA's comments 

Click below to view the FDA's draft guidances (10/3/14):

Framework for Regulatory Oversight of LDTs 

Notification and Medical Device Reporting for LDTs 

NILA News

12/5/2023
NILA and AAB Comment on FDA’s Proposed LDT Rule

11/15/2023
House Passes 1-Year Delay of PAMA Reimbursement Cuts

11/6/2023
NILA Urges Congress to Provide Immediate PAMA Relief

Laboratory Outreach Communications System (LOCS)

Click here for laboratory-related information and communications from the Centers for Disease Control and Prevention (CDC).